What does HERO mean?
HERO means Hirulog early reperfusion/occlusion trial
This acronym/slang usually belongs to Medical & Science category.
What is the abbreviation for Hirulog early reperfusion/occlusion trial?
Hirulog early reperfusion/occlusion trial can be abbreviated as HERO
|
|
Most popular questions people look for before coming to this page
Q: A: |
What does HERO stand for? HERO stands for "Hirulog early reperfusion/occlusion trial". |
Q: A: |
How to abbreviate "Hirulog early reperfusion/occlusion trial"? "Hirulog early reperfusion/occlusion trial" can be abbreviated as HERO. |
Q: A: |
What is the meaning of HERO abbreviation? The meaning of HERO abbreviation is "Hirulog early reperfusion/occlusion trial". |
Q: A: |
What is HERO abbreviation? One of the definitions of HERO is "Hirulog early reperfusion/occlusion trial". |
Q: A: |
What does HERO mean? HERO as abbreviation means "Hirulog early reperfusion/occlusion trial". |
Q: A: |
What is shorthand of Hirulog early reperfusion/occlusion trial? The most common shorthand of "Hirulog early reperfusion/occlusion trial" is HERO. |
Abbreviations or Slang with similar meaning
- EMGT - Early Manifest Glaucoma Trial
- ERSET - Early Randomized Surgical Epilepsy Trial
- TEDBC - Trial of Early Detection of Breast Cancer
- EFT - Early Field Trial
- ETCO - Early Total Cervix Occlusion
- ESCAT - Early Self-Controlled Anticoagulation Trial
- ECTG - Early Clinical Trial Group
- IDEAL - Initiating Dialysis Early and Late Trial
- EDIT - Early Diabetes Intervention Trial
- ELSAT - Early or Late Steroids in Asthma Trial
- EPVF - early post-occlusion ventricular fibrillation
- ERSET - Early Randomized Surgery for Epilepsy Trial
- EST - Early Stroke Trial
- HERO - Hirulog Early Reperfusion Occlusion
- TRENT - Trial of Early Nifedipine Treatment
- EDIT - Early Defibrillator Implantation Trial
- HERO - Hirulog and Early Reperfusion or Occlusion
- total - Total occlusion trial with angioplasty by using laser
- SHOT - Shunt Occlusion Trial
- BAROCCO - Balloon Angioplasty vs ROtacs for total Chronic Coronary Occlusion trial